We confirmed both in vitro and in vivo that YAP1/WWTR1/TEAD-dependent transcription is acutely activated following osimertinib treatment in EGFR mutant lung cancer and pharmacologic and genetic ablation of this complex strongly suppresses persister cells. This evidence concerns the gene EGFR and lung carcinoma.